Difference between revisions of "Lawford Davies Denoon"

From Powerbase
Jump to: navigation, search
m (law firms category)
Line 1: Line 1:
 
[[Lawford Davies Denoon]] is a London-based law firm which describes itself as specialising in life sciences (biotechnology). Its areas of expertise include human tissue and embryo research, in vitro fertilisation, and Advanced Therapy Medicinal Products, defined as medicines based on gene therapy, somatic cell therapy or tissue engineering.<ref>Lawford Davies Denoon (2012) [http://www.lawforddaviesdenoon.com/index.php?home Home page], acc 26 Nov 2012</ref>
 
[[Lawford Davies Denoon]] is a London-based law firm which describes itself as specialising in life sciences (biotechnology). Its areas of expertise include human tissue and embryo research, in vitro fertilisation, and Advanced Therapy Medicinal Products, defined as medicines based on gene therapy, somatic cell therapy or tissue engineering.<ref>Lawford Davies Denoon (2012) [http://www.lawforddaviesdenoon.com/index.php?home Home page], acc 26 Nov 2012</ref>
 +
 +
The firm's staff have become a resource for media stories that are supportive of development of contentious reproductive technologies.
 +
 +
Owner [[Alexander Denoon]] is a director and trustee of the [[Science Media Centre]] (see [[Science Media Centre]]).
 +
 +
Partner [[James Lawford Davies]] provided a quote to the SMC for media use, disagreeing with the Dept of Health's suggestion of a ban on the creation of human-animal hybrids for research purposes and complaining that "the proposals do little to move forward from the status quo".<ref>Science Media Centre (2006), [http://www.sciencemediacentre.org/scientists-respond-to-the-doh-review-of-the-human-fertilisation-and-embryology-act-2/ scientists respond to the DoH review of the Human Fertilisation and Embryology Act], Dec 13, acc 27 Nov 2012</ref>
 +
 +
Another lawyer in the firm, [[Julian Hitchcock]], during his previous employment a senior life sciences lawyer with [[Mills & Reeve]], lamented the outcome of a public consultation in which "a largely uninformed public was simply (and improbably) asked, 'whether the law should permit the creation of human-animal or chimera embryos'." As a result of this consultation, which Hitchcock said was characterised by the researchers' "complacency and failure to engage with the public", the UK government had proposed banning the creation of hybrid embryos in its forthcoming human tissue and embryos bill. In addition, the regulator, the [[Human Fertilisation and Embryology Authority]], had shelved applications to creates such embryos by scientists at [[King's College London]] and [[Newcastle University]].<ref>Clive Cookson (2007) [http://www.ft.com/cms/s/0/fc1bebc8-5b4a-11dc-8c32-0000779fd2ac.html#axzz2DpqOTWqz Scientific lobby wins backing for human-animal hybrid embryos], Financial Times, 5 Sept 2007, acc 1 Dec 2012</ref>
 +
 +
According to an article in the Financial Times, "Opinion started to change when scientists, realising belatedly what was at stake, started campaigning on the issue. In particular they persuaded the House of Commons science committee to hold an inquiry, which came out unanimously in favour of regulated research using hybrid embryos."<ref>Clive Cookson (2007) [http://www.ft.com/cms/s/0/fc1bebc8-5b4a-11dc-8c32-0000779fd2ac.html#axzz2DpqOTWqz Scientific lobby wins backing for human-animal hybrid embryos], Financial Times, 5 Sept 2007, acc 1 Dec 2012</ref>
 +
 +
A second public consultation, conducted by the [[Human Fertilisation and Embryology Authority]], "showed that many people who initially found the idea of hybrid embryos repugnant changed their minds once they were told what the research actually involved", according to the Financial Times article.
 +
 +
In the wake of these events, the government reversed its position, saying that new human tissues and embryos bill would permit the creation of human-animal embryos in some circumstances.<ref>Clive Cookson (2007) [http://www.ft.com/cms/s/0/fc1bebc8-5b4a-11dc-8c32-0000779fd2ac.html#axzz2DpqOTWqz Scientific lobby wins backing for human-animal hybrid embryos], Financial Times, 5 Sept 2007, acc 1 Dec 2012</ref>
 +
 +
Hitchcock approved of this result: "The thoroughness of the HFEA's consultation, which differed from the government's in providing an explanation of the work involved, has reached a very different - and welcome - result which augurs well for stem cell research and enterprise. It will hopefully persuade the Chief Medical Officer (Sir [[Liam Donaldson]]), who has previously voiced doubts about chimera/hybrid research, that the public truly is on board."<ref>Clive Cookson (2007) [http://www.ft.com/cms/s/0/fc1bebc8-5b4a-11dc-8c32-0000779fd2ac.html#axzz2DpqOTWqz Scientific lobby wins backing for human-animal hybrid embryos], Financial Times, 5 Sept 2007, acc 1 Dec 2012</ref>
 +
 +
Someone else who approved of the turnaround in public opinion was [[Fiona Fox]], director of the [[Science Media Centre]]. She was quoted in the same article as saying: "The HFEA consultation on public attitudes to human-animal embryos shows that when the public feel they understand the science and can see which diseases the researchers are trying to tackle, support swings strongly in favour of allowing research.
 +
 +
"Over 60 per cent of those in favour of embryo research were also in favour of the HFEA licensing the creation of human/animal embryos."<ref>Clive Cookson (2007) [http://www.ft.com/cms/s/0/fc1bebc8-5b4a-11dc-8c32-0000779fd2ac.html#axzz2DpqOTWqz Scientific lobby wins backing for human-animal hybrid embryos], Financial Times, 5 Sept 2007, acc 1 Dec 2012</ref>
  
 
==People==
 
==People==

Revision as of 21:14, 1 December 2012

Lawford Davies Denoon is a London-based law firm which describes itself as specialising in life sciences (biotechnology). Its areas of expertise include human tissue and embryo research, in vitro fertilisation, and Advanced Therapy Medicinal Products, defined as medicines based on gene therapy, somatic cell therapy or tissue engineering.[1]

The firm's staff have become a resource for media stories that are supportive of development of contentious reproductive technologies.

Owner Alexander Denoon is a director and trustee of the Science Media Centre (see Science Media Centre).

Partner James Lawford Davies provided a quote to the SMC for media use, disagreeing with the Dept of Health's suggestion of a ban on the creation of human-animal hybrids for research purposes and complaining that "the proposals do little to move forward from the status quo".[2]

Another lawyer in the firm, Julian Hitchcock, during his previous employment a senior life sciences lawyer with Mills & Reeve, lamented the outcome of a public consultation in which "a largely uninformed public was simply (and improbably) asked, 'whether the law should permit the creation of human-animal or chimera embryos'." As a result of this consultation, which Hitchcock said was characterised by the researchers' "complacency and failure to engage with the public", the UK government had proposed banning the creation of hybrid embryos in its forthcoming human tissue and embryos bill. In addition, the regulator, the Human Fertilisation and Embryology Authority, had shelved applications to creates such embryos by scientists at King's College London and Newcastle University.[3]

According to an article in the Financial Times, "Opinion started to change when scientists, realising belatedly what was at stake, started campaigning on the issue. In particular they persuaded the House of Commons science committee to hold an inquiry, which came out unanimously in favour of regulated research using hybrid embryos."[4]

A second public consultation, conducted by the Human Fertilisation and Embryology Authority, "showed that many people who initially found the idea of hybrid embryos repugnant changed their minds once they were told what the research actually involved", according to the Financial Times article.

In the wake of these events, the government reversed its position, saying that new human tissues and embryos bill would permit the creation of human-animal embryos in some circumstances.[5]

Hitchcock approved of this result: "The thoroughness of the HFEA's consultation, which differed from the government's in providing an explanation of the work involved, has reached a very different - and welcome - result which augurs well for stem cell research and enterprise. It will hopefully persuade the Chief Medical Officer (Sir Liam Donaldson), who has previously voiced doubts about chimera/hybrid research, that the public truly is on board."[6]

Someone else who approved of the turnaround in public opinion was Fiona Fox, director of the Science Media Centre. She was quoted in the same article as saying: "The HFEA consultation on public attitudes to human-animal embryos shows that when the public feel they understand the science and can see which diseases the researchers are trying to tackle, support swings strongly in favour of allowing research.

"Over 60 per cent of those in favour of embryo research were also in favour of the HFEA licensing the creation of human/animal embryos."[7]

People

Affiliations

Contact

Address:
...
...
...
...
Phone:
...
Email:
...
Website:
...

Resources

Notes

  1. Lawford Davies Denoon (2012) Home page, acc 26 Nov 2012
  2. Science Media Centre (2006), scientists respond to the DoH review of the Human Fertilisation and Embryology Act, Dec 13, acc 27 Nov 2012
  3. Clive Cookson (2007) Scientific lobby wins backing for human-animal hybrid embryos, Financial Times, 5 Sept 2007, acc 1 Dec 2012
  4. Clive Cookson (2007) Scientific lobby wins backing for human-animal hybrid embryos, Financial Times, 5 Sept 2007, acc 1 Dec 2012
  5. Clive Cookson (2007) Scientific lobby wins backing for human-animal hybrid embryos, Financial Times, 5 Sept 2007, acc 1 Dec 2012
  6. Clive Cookson (2007) Scientific lobby wins backing for human-animal hybrid embryos, Financial Times, 5 Sept 2007, acc 1 Dec 2012
  7. Clive Cookson (2007) Scientific lobby wins backing for human-animal hybrid embryos, Financial Times, 5 Sept 2007, acc 1 Dec 2012